510(k) · Cleared
ClearedXTRA Collection sets; XTRA Sequestration set X
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Sorin Group Italia S.R.L. · CAC Apparatus, Autotransfusion
Cleared on Aug 16, 2024 as substantially equivalent to K101586 (Sorin Group Italia S.R.L., 2010) and 1 other predicate after a 106-day review. Its family tree reaches back 4 generations to 1989.
- Decided
- Aug 16, 2024
- Review
- 106 days
- Class
- Class II
- Product code
- CAC
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 4 generations to K884564 (1989). 11 ancestors in all. No later device cites it as a predicate yet.
- Root · 4 generations backK884564 Shiley Therapeutic Autotransfusion System-ProgrammShiley, Inc. · 1989
- 3 generations backK982650 Autologous Blood Management System (Abms)Dideco S.P.A. · 1998 · Recalled
- 2 generations backK020647 Dideco ElectaDideco S.P.A. · 2002 · Recalled
- 1 generation backK101586 Xtra Autotransfusion SystemSorin Group Italia S.R.L. · 2010
- This deviceK241236 XTRA Collection sets; XTRA Sequestration set XSorin Group Italia S.R.L. · 2024
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K884564 | Shiley Therapeutic Autotransfusion System-Programm | Shiley, Inc. | 1989 | — |
| −3 | K982650 | Autologous Blood Management System (Abms) | Dideco S.P.A. | 1998 | 2 |
| −2 | K020647 | Dideco Electa | Dideco S.P.A. | 2002 | 2 |
| −1 | K101586 | Xtra Autotransfusion System | Sorin Group Italia S.R.L. | 2010 | — |
| 0 (this device) | K241236 | XTRA Collection sets; XTRA Sequestration set X | Sorin Group Italia S.R.L. | 2024 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 1 | 0 |
| 1995 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2010 | 1 | 0 |
| 2013 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CAC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new CAC device
- #1 K240426 Aventus Clot Management Systemscore 11.2 · 4 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K101586 | Xtra Autotransfusion SystemSummary page 6…cleared predicate device. Both models have the same fundamental scientific technology and intended use: 510(k) Number: K101586 Device Trade Name: XTRA autotransfusion system Classification Name: Apparatus, Autotran… | 2010 |
| * | K131103 | Xres Blood Collection Reservoir Xres 120MICROMETER Blood Collection ReservoirSummary page 6…devices. Both models have the same fundamental scientific technology and intended use: 510(k) Number: K101586 K131103 XTRA autotransfusion XRES/XRES 120µm Blood Device Trade Name:… | 2013 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 35 years and passes through 3 companies; a new generation was cleared every 9.6 years on median.
- 2 of the 11 ancestors have a recall of any class.
- 3 other devices also cite its predicate K101586.
How does its category compare?
All CAC devicesCAC Apparatus, Autotransfusion: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.
FDA decisions per year · CAC
3in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · CAC
91in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · CAC
7in 2023
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · CAC
128in 2025
MAUDE reports naming product code CAC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 1 | 35 |
| 2008 | 1 | — | 5 | 12 |
| 2009 | 0 | — | 25 | 68 |
| 2010 | 4 | 123 | 3 | 115 |
| 2011 | 2 | — | 3 | 939 |
| 2012 | 3 | 90 | 0 | 249 |
| 2013 | 1 | — | 9 | 153 |
| 2014 | 3 | 269 | 0 | 90 |
| 2015 | 0 | — | 0 | 87 |
| 2016 | 2 | — | 0 | 73 |
| 2017 | 1 | — | 2 | 88 |
| 2018 | 2 | — | 2 | 87 |
| 2019 | 1 | — | 23 | 64 |
| 2020 | 1 | — | 0 | 108 |
| 2021 | 4 | 155 | 0 | 73 |
| 2022 | 1 | — | 0 | 65 |
| 2023 | 2 | — | 7 (2) | 39 |
| 2024 | 3 | 91 | 0 | 129 |
| 2025 | 0 | — | 0 | 128 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
For XTRA Collection sets: "The XTRA Autotransufion System (including the XTRA Collection sets) is indicated for intraoperative recovery of blood, washing of blood collected in the postoperative period, and preoperative sequestration (with indirect patient connection). Typical clinical applications of autotransfusion include the following surgical specialties: » Cardiovascular * Orthopedics * Thoracic * Transplant surgery * Emergency (Trauma) *…
Read the full statement (132 words)
For XTRA Collection sets:
"The XTRA Autotransufion System (including the XTRA Collection sets) is indicated for intraoperative recovery of blood, washing of blood collected in the postoperative period, and preoperative sequestration (with indirect patient connection). Typical clinical applications of autotransfusion include the following surgical specialties:
» Cardiovascular
* Orthopedics
* Thoracic
* Transplant surgery
* Emergency (Trauma)
* Neurosurgery
* Obstetrics and Gynecology
* Urology"
For XTRA Sequestration set X:
"The XTRA Autotransufion System (including the XTRA Sequestration set X) is indicated for intraoperative recovery of blood, washing of blood collected in the postoperative period, and preoperative sequestration (with indirect patient connection). Typical clinical applications of autotransfusion include the following surgical specialties:
» Cardiovascular
* Orthopedics
* Thoracic
* Transplant surgery
* Emergency (Trauma)
* Neurosurgery
* Obstetrics and Gynecology
* Urology"
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K241236 · printed Nov 6, 2026
Cite this page
510(k) Report. “K241236: XTRA Collection sets; XTRA Sequestration set X.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K241236
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026